1Mark. DB, Nelson CL. Confining evolution of therapy for coronary artery disease[J]. Circulation, 1994,89:2015 - 2025. 被引量：1
2Lopaschuk GD, Stanley WC315.. Glucose metabolism in the ischemic heart[J]. Circulation, 1997,95:313 - 被引量：1
3Regitz V, Shug A, Fleck E. Defective myocardiac, carnitinl metablism in congestive heart faicure seconday to dilated cardiomyopathy and to coronany, hypertensive and valvular heart disease[J]. Am J carttiol, 1990,65:755 - 760. 被引量：1
1Bauersachs J, Galuppo P, Fraccarollo D, et al. Improvement of left ventricular remodeling and function by hydroxymethylglutaryl coenzyme A reductase inhibition with cerivastatin in rats with heart failure after myocardial infarction [J]. Circulation, 2001 被引量：1
2Hayashidani S, Tsutsui H, Shiomi T, et al. Fluvastatin, a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, attenuates left ventricular remodeling and failure after experimental myocardial infarction [J]. Circulation, 2002, 105:868 被引量：1
3Patel R, Nagueh SF, Tsybouleva N, et al. Simvastatin induces regression of cardiac hypertrophy and fibrosis and improves cardiac function in a transgenic rabbit model of human hypertrophic cardiomyopathy [J]. Circulation, 2001,104:317 被引量：1
4Laufs U, La Fata V, Plutzky J, et al. Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors [J]. Circulation, 1998, 97:1129. 被引量：1
5Oi S, Haneda T, Osaki J, et al. Lovastatin prevents angiotensin II-induced cardiac hypertrophy in cultured neonatal rat heart cells [J]. Eur J Pharmacol, 1999, 376:139 被引量：1
6Luo JD, Zhang WW, Zhang GP, et al. Simvastatin inhibits cardiac hypertrophy and angiotensin-converting enzyme activity in rats with aortic stenosis [J]. Clin Exp Pharmacol Physiol, 1999, 26:903 被引量：1
7Dechend R, Fiebeler A, Park JK, et al. Amelioration of angiotensin II-induced cardiac injury by a 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitor [J]. Circulation, 2001,104:576 被引量：1
8Luan Z, Chase AJ, Newby AC. Statins inhibit secretion of metalloproteinases-1, -2, -3, and -9 from vascular smooth muscle cells and macrophages[J]. Arterioscler Thromb Vasc Biol, 2003, 23:769 被引量：1
9Ikeda U, Shimpo M, Ohki R, et al. Fluvastatin inhibits matrix metalloproteinase-1 expression in human vascular endothelial cells [J]. Hypertension, 2000, 36:325 被引量：1
10Bellosta S, Via D, Canavesi M, et al. HMG-CoA reductase inhibitors reduce MMP-9 secretion by macrophages [J]. Arterioscler Thromb Vasc Biol, 1998, 18:1671 被引量：1
1Nomenclature and criteria for diagnosis of ischemic heart disease. Report of the joint international and federation of cardiology World Health Organization task force on standardization of clinical nomenclature[J].Circulation,1979,(06):607-609. 被引量：1
2Feola M,Biggi A,Francini A. Placebo of trimetazidine (99m) Tc Tetrofosm in myocardial SPECT and low-dose dobutamine echocardiography in liberating myocardium[J].Archives of Medical Research,2006,(01):117-122.doi:10.1016/j.arcmed.2005.05.011. 被引量：1
